ABT-263, a BCL-2 inhibitor, selectively eliminates latently HIV-1-infected cells without viral reactivation

• Jeong Eun Kang ,

  Roles Data curation, Formal analysis, Investigation, Methodology

  ¶‡ JEK and HWS are co-first authors on this work

  Affiliation Division of Chronic Viral Disease Research, Center for Emerging Virus Research, National Institute of Health, Cheongju, Republic of Korea

  ⨯
• Hyun Wook Seo ,

  Roles Funding acquisition, Investigation, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: hyunwookseo@korea.kr (HWS); kmc755@korea.kr (C-H Y)

  ¶‡ JEK and HWS are co-first authors on this work

  Affiliation Division of Chronic Viral Disease Research, Center for Emerging Virus Research, National Institute of Health, Cheongju, Republic of Korea

  https://orcid.org/0000-0003-0298-8254

  ⨯
• Dong-Eun Kim,

  Roles Formal analysis, Investigation, Methodology

  Affiliation Division of Chronic Viral Disease Research, Center for Emerging Virus Research, National Institute of Health, Cheongju, Republic of Korea

  ⨯
• Young Hyun Shin,

  Roles Formal analysis, Investigation, Methodology

  Affiliation Division of Chronic Viral Disease Research, Center for Emerging Virus Research, National Institute of Health, Cheongju, Republic of Korea

  ⨯
• Songmee Bae,

  Roles Formal analysis, Funding acquisition

  Affiliation Division of Chronic Viral Disease Research, Center for Emerging Virus Research, National Institute of Health, Cheongju, Republic of Korea

  ⨯
• Cheol-Hee Yoon

  Roles Conceptualization, Project administration, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: hyunwookseo@korea.kr (HWS); kmc755@korea.kr (C-H Y)

  Affiliation Division of Chronic Viral Disease Research, Center for Emerging Virus Research, National Institute of Health, Cheongju, Republic of Korea

  https://orcid.org/0000-0002-5696-0567

  ⨯